This chapter of the podcast discusses the challenges and risks involved in diagnosing and treating bipolar disorder and depression, highlighting the long and uncertain process of finding the right treatment. It compares the remission rates of conventional treatments to experimental interventions like TMS and ketamine, and explores the potential benefits of neuromodulation treatments for conditions that may not be eligible for psychedelic therapy trials.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode